Diadema Partners »

Centessa Pharmaceuticals shares owned by Diadema Partners

Quarter-by-quarter ownership of Centessa Pharmaceuticals (CNTA) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Centessa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Centessa Pharmaceuticals held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Centessa Pharmaceuticals by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.8M 111k 25.01

More positions owned by Diadema Partners

Viking Therapeutics (VKTX)
Vertex Pharmaceuticals Incorporated (VRTX)
Bridgebio Pharma (BBIO)
Spdr Series Trust State Street Spd Put Option (XBI)
Praxis Precision Medicines I Com New Put Option (PRAX)
Johnson & Johnson (JNJ)
Avidity Biosciences Ord Call Option (RNA)
Capricor Therapeutics Com New (CAPR)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Jazz Pharmaceuticals Shs Usd Call Option (JAZZ)
Terns Pharmaceuticals (TERN)
Apogee Therapeutics Call Option (APGE)
Structure Therapeutics Sponsored Ads Call Option (GPCR)
Regeneron Pharmaceuticals (REGN)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Diadema Partners

Top funds holding Centessa Pharmaceuticals

Medicxi Ventures Management
venBio Select Advisor
Adage Capital Partners GP
General Atlantic
FMR
Henderson Group
Farallon Capital Management
TCG Crossover Management
Siren
EcoR1 Capital
Perceptive Advisors
Franklin Resources
Federated Investors
First Light Asset Management
Braidwell

View all funds holding Centessa Pharmaceuticals